Global Information
회사소개 | 문의 | 비교리스트

세계의 색전술 시장 : 적응증별, 제품별, 유형별, 최종사용자별, 지역별 예측 및 기회(-2025년)

Global Embolotherapy Market By Indication, By Product, By Type, By End-User, By Region, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 934748
페이지 정보 영문 112 Pages
가격
US $ 4,450 ₩ 5,070,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,209,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,767,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 색전술 시장 : 적응증별, 제품별, 유형별, 최종사용자별, 지역별 예측 및 기회(-2025년) Global Embolotherapy Market By Indication, By Product, By Type, By End-User, By Region, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 112 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 색전술 시장은 만성질환 발생률 상승, 환자 집단 증가, 의료비 급증 등의 요인으로 인해 예측기간 동안 상당한 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다. 색전술 기기의 급속한 기술 발전 또한 2025년까지 시장 성장을 뒷받침할 것으로 예상됩니다.

세계의 색전술(Embolotherapy) 시장을 조사했으며, 지역별 시장 전망, 시장 역학, 주요 동향, 경쟁 상황, 전략적 제안 등의 정보를 전해드립니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 코로나19(COVID-19)가 세계 시장에 미치는 영향

제4장 개요

제5장 고객의 견해

제6장 세계 시장 전망

  • 시장 규모와 예측
    • 금액 및 수량 기준
  • 시장 점유율과 예측
    • 적응증(암, 소화기질환, 신경질환, 말초혈관질환, 비뇨기과 및 신장 질환)
    • 제품별(혈전제(Embolic Coils, Embolic Plug Systems, Liquid Embolic Agents, Microspheres, Detachable Balloon), 지원 기기(마이크로카테터, 가이드와이어))
    • 유형별(화학 색전술, 방사선 색전술, 동맥 색전술, 혼합)
    • 최종사용자(병원, 외래수술센터(ASC) 등)
    • 기업별(2019)
    • 지역별
  • 시장 매력 지수

제7장 아시아태평양 시장 전망

  • 시장 규모와 예측
    • 금액 및 수량 기준
  • 시장 점유율과 예측
    • 적응증별
    • 혈전제별
    • 유형별
    • 최종사용자별
    • 국가별
  • 시장 매력 지수
  • 아시아태평양 : 국가 분석
    • 중국 시장 전망
    • 인도 시장 전망
    • 일본 시장 전망
    • 한국 시장 전망
    • 싱가포르 시장 전망
    • 호주 시장 전망

제8장 유럽 시장 전망

  • 시장 규모와 예측
    • 금액 및 수량 기준
  • 시장 점유율과 예측
    • 적응증별
    • 혈전제별
    • 유형별
    • 최종사용자별
    • 국가별
  • 시장 매력 지수
  • 유럽 : 국가 분석
    • 프랑스 시장 전망
    • 독일 시장 전망
    • 영국 시장 전망
    • 이탈리아 시장 전망
    • 러시아 시장 전망
    • 스페인 시장 전망

제9장 북미 시장 전망

  • 시장 규모와 예측
    • 금액 및 수량 기준
  • 시장 점유율과 예측
    • 적응증별
    • 혈전제별
    • 유형별
    • 최종사용자별
    • 국가별
  • 시장 매력 지수
  • 북미 : 국가 분석
    • 미국 시장 전망
    • 멕시코 시장 전망
    • 캐나다 시장 전망

제10장 남미 시장 전망

  • 시장 규모와 예측
    • 금액 및 수량 기준
  • 시장 점유율과 예측
    • 적응증별
    • 혈전제별
    • 유형별
    • 최종사용자별
    • 국가별
  • 시장 매력 지수
  • 남미 : 국가 분석
    • 브라질 시장 전망
    • 아르헨티나 시장 전망
    • 콜롬비아 시장 전망

제11장 중동 및 아프리카 시장 전망

  • 시장 규모와 예측
    • 금액 및 수량 기준
  • 시장 점유율과 예측
    • 적응증별
    • 혈전제별
    • 유형별
    • 최종사용자별
    • 국가별
  • 시장 매력 지수
  • 중동 및 아프리카 : 국가 분석
    • 남아프리카공화국 시장 전망
    • 사우디아라비아 시장 전망
    • 아랍에미리트(UAE) 시장 전망

제12장 시장 역학

  • 성장 촉진요인
  • 과제

제13장 시장 동향 및 동향

제14장 경쟁 상황

  • 경쟁 전망
  • 기업 개요(주요 기업)
    • Abbott Laboratories
    • ABK Biomedical Inc
    • Acandis GmbH
    • AngioDynamics Inc
    • Becton Dickinson and Company
    • Boston Scientific Corporation
    • Cook Medical
    • Guerbet
    • Imbiotechnologies Ltd.
    • Johnson & Johnson
    • Kaneka Corporation
    • Medtronic
    • Meril Life Sciences Pvt. Ltd.
    • Merit Medical Systems
    • Merit Medical Systems, Inc.
    • Penumbra, Inc.
    • Simbionix USA Corporation
    • Sirtex Medical Limited
    • Stryker Corporation
    • Terumo Corporation

제15장 전략적 권장사항

제16장 면책조항

LSH 20.06.05

Global embolotherapy market is expected to register significant CAGR during the forecast period owing to factors like rising incidence of chronic diseases, increasing patient pool and surging healthcare spending. Additionally, rapid technological advancements in embolotherapy devices is also anticipated to boost the market growth until 2025.

Embolotherapy is a type of endovascular treatment used for controlling bleeding and reduce tumor by restricting or blocking abnormal blood cells. To achieve blocking, embolotherapy uses minimally invasive methods and other embolic agents like gel foam, coils, balloons and angiographic catheters to achieve positive results. Additionally, adoption of embolic procedures for the management of various diseases is increasing rapidly as most of the patients who are diagnosed at intermediate stage and advanced stage, do not respond to curative therapies.

The global embolotherapy market faces some restraints which include risks and challenges associated with embolization and dearth of skilled radiologists. Also, unfavorable regulatory scenario might also pose challenge to the growth of embolotherapy market.

The global embolotherapy market is segmented based on indication, product, type, end-user and region. Based on end-user, the market is segmented into hospitals, clinics, ambulatory surgical centers and others. In 2019, hospitals category accounted for the largest market share in the global embolotherapy market. The reason behind this can be attributed to growing adoption of minimally invasive procedures promoted by the hospitals.

Major players operating in the global embolotherapy market include Abbott Laboratories , ABK Biomedical Inc, Acandis GmbH, AngioDynamics Inc, Becton Dickinson and Company, Boston Scientific Corporation, Cook Medical, Guerbet, Imbiotechnologies Ltd., Johnson & Johnson, Kaneka Corporation, Medtronic, Meril Life Sciences Pvt. Ltd., Merit Medical Systems, Inc., Penumbra, Inc., Simbionix USA Corporation, Sirtex Medical Limited, Stryker Corporation, Terumo Corporation and others. The companies are engaging in research and development of new products to increase their market share. Also, other growth strategies like partnerships, and strategic acquisitions are helping companies to boost their presence in the global embolotherapy market.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global embolotherapy market.
  • To classify and forecast global embolotherapy market based on indication, product, type, end-user and regional distribution.
  • To identify drivers and challenges for global embolotherapy market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global embolotherapy market.
  • To conduct pricing analysis for global embolotherapy market.
  • To identify and analyze the profile of leading players operating in global embolotherapy market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/clinics and presence of all major players across the globe.

TechSci Research calculated the market size of global embolotherapy market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Embolotherapy hospitals/clinics, research organizations and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to embolotherapy
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global embolotherapy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Indication:

Cancer

Gastrointestinal Disorders

Neurological Diseases

Peripheral Vascular Disease

Urological & Nephrological Disorders

  • Market, By Product:

Embolic Agents

  • Embolic Coils
  • Embolic Plug Systems
  • Liquid Embolic Agents
  • Microspheres
  • Detachable Balloons

Support Devices

  • Microcatheters
  • Guidewires
  • Market, By Type:

Chemoembolization

Radioembolization

Arterial Embolization

Combination

  • Market, By End-User:

Hospitals

Clinics

Ambulatory Surgical Centers

Others

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global embolotherapy market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Embolotherapy Market

4. Executive Summary

5. Voice of Customer

6. Global Embolotherapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Indication (Cancer, Gastrointestinal Disorders, Neurological Diseases, Peripheral Vascular Disease, Urological & Nephrological Disorders)
    • 6.2.2. By Product (Embolic Agents (Embolic Coils, Embolic Plug Systems, Liquid Embolic Agents, Microspheres, Detachable Balloons), Support Devices (Microcatheters, Guidewires))
    • 6.2.3. By Type (Chemoembolization, Radioembolization, Arterial embolization, Combination)
    • 6.2.4. By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Others)
    • 6.2.5. By Company (2019)
    • 6.2.6. By Region
  • 6.3. Market Attractiveness Index

7. Asia-Pacific Embolotherapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Indication
    • 7.2.2. By Embolic agents
    • 7.2.3. By Types
    • 7.2.4. By End-User
    • 7.2.5. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. Asia-Pacific: Country Analysis
    • 7.4.1. China Embolotherapy Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Indication
        • 7.4.1.2.2. By Embolic agents
        • 7.4.1.2.3. By Types
        • 7.4.1.2.4. By End-User
    • 7.4.2. India Embolotherapy Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Indication
        • 7.4.2.2.2. By Embolic agents
        • 7.4.2.2.3. By Types
        • 7.4.2.2.4. By End-User
    • 7.4.3. Japan Embolotherapy Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Indication
        • 7.4.3.2.2. By Embolic agents
        • 7.4.3.2.3. By Types
        • 7.4.3.2.4. By End-User
    • 7.4.4. South Korea Embolotherapy Market Outlook
      • 7.4.4.1. Market Size & Forecast
        • 7.4.4.1.1. By Value
      • 7.4.4.2. Market Share & Forecast
        • 7.4.4.2.1. By Indication
        • 7.4.4.2.2. By Embolic agents
        • 7.4.4.2.3. By Types
        • 7.4.4.2.4. By End-User
    • 7.4.5. Singapore Embolotherapy Market Outlook
      • 7.4.5.1. Market Size & Forecast
        • 7.4.5.1.1. By Value
      • 7.4.5.2. Market Share & Forecast
        • 7.4.5.2.1. By Indication
        • 7.4.5.2.2. By Embolic agents
        • 7.4.5.2.3. By Types
        • 7.4.5.2.4. By End-User
    • 7.4.6. Australia Embolotherapy Market Outlook
      • 7.4.6.1. Market Size & Forecast
        • 7.4.6.1.1. By Value
      • 7.4.6.2. Market Share & Forecast
        • 7.4.6.2.1. By Indication
        • 7.4.6.2.2. By Embolic agents
        • 7.4.6.2.3. By Types
        • 7.4.6.2.4. By End-User

8. Europe Embolotherapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Indication
    • 8.2.2. By Embolic agents
    • 8.2.3. By Types
    • 8.2.4. By End-User
    • 8.2.5. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. Europe: Country Analysis
    • 8.4.1. France Embolotherapy Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Indication
        • 8.4.1.2.2. By Embolic agents
        • 8.4.1.2.3. By Types
        • 8.4.1.2.4. By End-User
    • 8.4.2. Germany Embolotherapy Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Indication
        • 8.4.2.2.2. By Embolic agents
        • 8.4.2.2.3. By Types
        • 8.4.2.2.4. By End-User
    • 8.4.3. United Kingdom Embolotherapy Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Indication
        • 8.4.3.2.2. By Embolic agents
        • 8.4.3.2.3. By Types
        • 8.4.3.2.4. By End-User
    • 8.4.4. Italy Embolotherapy Market Outlook
      • 8.4.4.1. Market Size & Forecast
        • 8.4.4.1.1. By Value
      • 8.4.4.2. Market Share & Forecast
        • 8.4.4.2.1. By Indication
        • 8.4.4.2.2. By Embolic agents
        • 8.4.4.2.3. By Types
        • 8.4.4.2.4. By End-User
    • 8.4.5. Russia Embolotherapy Market Outlook
      • 8.4.5.1. Market Size & Forecast
        • 8.4.5.1.1. By Value
      • 8.4.5.2. Market Share & Forecast
        • 8.4.5.2.1. By Indication
        • 8.4.5.2.2. By Embolic agents
        • 8.4.5.2.3. By Types
        • 8.4.5.2.4. By End-User
    • 8.4.6. Spain Embolotherapy Market Outlook
      • 8.4.6.1. Market Size & Forecast
        • 8.4.6.1.1. By Value
      • 8.4.6.2. Market Share & Forecast
        • 8.4.6.2.1. By Indication
        • 8.4.6.2.2. By Embolic agents
        • 8.4.6.2.3. By Types
        • 8.4.6.2.4. By End-User

9. North America Embolotherapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Indication
    • 9.2.2. By Embolic agents
    • 9.2.3. By Types
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. North America: Country Analysis
    • 9.4.1. United States Embolotherapy Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Indication
        • 9.4.1.2.2. By Embolic agents
        • 9.4.1.2.3. By Types
        • 9.4.1.2.4. By End-User
    • 9.4.2. Mexico Embolotherapy Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Indication
        • 9.4.2.2.2. By Embolic agents
        • 9.4.2.2.3. By Types
        • 9.4.2.2.4. By End-User
    • 9.4.3. Canada Embolotherapy Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Indication
        • 9.4.3.2.2. By Embolic agents
        • 9.4.3.2.3. By Types
        • 9.4.3.2.4. By End-User

10. South America Embolotherapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Indication
    • 10.2.2. By Embolic agents
    • 10.2.3. By Types
    • 10.2.4. By End-User
    • 10.2.5. By Country
  • 10.3. Market Attractiveness Index
  • 10.4. South America: Country Analysis
    • 10.4.1. Brazil Embolotherapy Market Outlook
      • 10.4.1.1. Market Size & Forecast
        • 10.4.1.1.1. By Value
      • 10.4.1.2. Market Share & Forecast
        • 10.4.1.2.1. By Indication
        • 10.4.1.2.2. By Embolic agents
        • 10.4.1.2.3. By Types
        • 10.4.1.2.4. By End-User
    • 10.4.2. Argentina Embolotherapy Market Outlook
      • 10.4.2.1. Market Size & Forecast
        • 10.4.2.1.1. By Value
      • 10.4.2.2. Market Share & Forecast
        • 10.4.2.2.1. By Indication
        • 10.4.2.2.2. By Embolic agents
        • 10.4.2.2.3. By Types
        • 10.4.2.2.4. By End-User
    • 10.4.3. Colombia Embolotherapy Market Outlook
      • 10.4.3.1. Market Size & Forecast
        • 10.4.3.1.1. By Value
      • 10.4.3.2. Market Share & Forecast
        • 10.4.3.2.1. By Indication
        • 10.4.3.2.2. By Embolic agents
        • 10.4.3.2.3. By Types
        • 10.4.3.2.4. By End-User

11. Middle East and Africa Embolotherapy Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value & Volume
  • 11.2. Market Share & Forecast
    • 11.2.1. By Indication
    • 11.2.2. By Embolic agents
    • 11.2.3. By Types
    • 11.2.4. By End-User
    • 11.2.5. By Country
  • 11.3. Market Attractiveness Index
  • 11.4. MEA: Country Analysis
    • 11.4.1. South Africa Embolotherapy Market Outlook
      • 11.4.1.1. Market Size & Forecast
        • 11.4.1.1.1. By Value
      • 11.4.1.2. Market Share & Forecast
        • 11.4.1.2.1. By Indication
        • 11.4.1.2.2. By Embolic agents
        • 11.4.1.2.3. By Types
        • 11.4.1.2.4. By End-User
    • 11.4.2. Saudi Arabia Embolotherapy Market Outlook
      • 11.4.2.1. Market Size & Forecast
        • 11.4.2.1.1. By Value
      • 11.4.2.2. Market Share & Forecast
        • 11.4.2.2.1. By Indication
        • 11.4.2.2.2. By Embolic agents
        • 11.4.2.2.3. By Types
        • 11.4.2.2.4. By End-User
    • 11.4.3. UAE Embolotherapy Market Outlook
      • 11.4.3.1. Market Size & Forecast
        • 11.4.3.1.1. By Value
      • 11.4.3.2. Market Share & Forecast
        • 11.4.3.2.1. By Indication
        • 11.4.3.2.2. By Embolic agents
        • 11.4.3.2.3. By Types
        • 11.4.3.2.4. By End-User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. Abbott Laboratories
    • 14.2.2. ABK Biomedical Inc
    • 14.2.3. Acandis GmbH
    • 14.2.4. AngioDynamics Inc
    • 14.2.5. Becton Dickinson and Company
    • 14.2.6. Boston Scientific Corporation
    • 14.2.7. Cook Medical
    • 14.2.8. Guerbet
    • 14.2.9. Imbiotechnologies Ltd.
    • 14.2.10. Johnson & Johnson
    • 14.2.11. Kaneka Corporation
    • 14.2.12. Medtronic
    • 14.2.13. Meril Life Sciences Pvt. Ltd.
    • 14.2.14. Merit Medical Systems
    • 14.2.15. Merit Medical Systems, Inc.
    • 14.2.16. Penumbra, Inc.
    • 14.2.17. Simbionix USA Corporation
    • 14.2.18. Sirtex Medical Limited
    • 14.2.19. Stryker Corporation
    • 14.2.20. Terumo Corporation

15. Strategic Recommendations

16. About Us & Disclaimer

Back to Top
전화 문의
F A Q